[A case of recurrent squamous cell carcinoma of cervix successfully treated with BOMP]. 1996

R Matsui, and K Kashihara, and T Higashi, and K Seo, and Y Taoka, and S Yoshida, and H Nishitani, and Y Takegawa, and Y Hukumura
Dept. of Radiology, Tokushima University School of Medicine.

Combination chemotherapy consisting of bleomycin, vincristine, mitomycin C and cisplatin (BOMP) was applied to a case (57 years old) with recurrence of squamous cell carcinoma of the cervix. The patient with FIGO stage IIIb cervical carcinoma had been treated with radiotherapy seven years ago. She was affected by malignant pericardial effusion, and was treated with direct intrapericardial administration of cisplatin (20 mg). After instillation, ultrasonography and computed tomography showed the wall thickening of colon and marked ascites. Barium enema showed the circumferential narrowing and serrations of colon, and it was diagnosed to be carcinomatous peritonitis. She was treated with BOMP consisting of BLM (5 mg, i.m., days 1 - 5), VCR (1 mg, i.v., day 5'), MMC (8 mg, i.v., day 5), and CDDP (70 mg, d.i.v., day 5). After three courses of BOMP therapy, she achieved a complete response with few toxic effects and did not require special care. She has been free of disease for six months and her performance status is 0. This encouraging result warrants the use of this combination chemotherapy regimen in other patients with recurrent squamous cell carcinoma of the cervix.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D010493 Pericarditis Inflammation of the PERICARDIUM from various origins, such as infection, neoplasm, autoimmune process, injuries, or drug-induced. Pericarditis usually leads to PERICARDIAL EFFUSION, or CONSTRICTIVE PERICARDITIS. Pleuropericarditis
D010538 Peritonitis INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs. Primary Peritonitis,Secondary Peritonitis,Peritonitis, Primary,Peritonitis, Secondary
D001761 Bleomycin A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. BLEO-cell,Blanoxan,Blenoxane,Bleolem,Bleomicina,Bleomycin A(2),Bleomycin A2,Bleomycin B(2),Bleomycin B2,Bleomycin Sulfate,Bleomycins,Bleomycinum Mack,Bléomycine Bellon,BLEO cell,BLEOcell,Bellon, Bléomycine,Mack, Bleomycinum,Sulfate, Bleomycin
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R Matsui, and K Kashihara, and T Higashi, and K Seo, and Y Taoka, and S Yoshida, and H Nishitani, and Y Takegawa, and Y Hukumura
February 2016, Clinical genitourinary cancer,
R Matsui, and K Kashihara, and T Higashi, and K Seo, and Y Taoka, and S Yoshida, and H Nishitani, and Y Takegawa, and Y Hukumura
November 1995, Kyobu geka. The Japanese journal of thoracic surgery,
R Matsui, and K Kashihara, and T Higashi, and K Seo, and Y Taoka, and S Yoshida, and H Nishitani, and Y Takegawa, and Y Hukumura
March 2024, Dermatology reports,
R Matsui, and K Kashihara, and T Higashi, and K Seo, and Y Taoka, and S Yoshida, and H Nishitani, and Y Takegawa, and Y Hukumura
January 2010, The Journal of reproductive medicine,
R Matsui, and K Kashihara, and T Higashi, and K Seo, and Y Taoka, and S Yoshida, and H Nishitani, and Y Takegawa, and Y Hukumura
May 2005, The Journal of laryngology and otology,
R Matsui, and K Kashihara, and T Higashi, and K Seo, and Y Taoka, and S Yoshida, and H Nishitani, and Y Takegawa, and Y Hukumura
February 2013, Gan to kagaku ryoho. Cancer & chemotherapy,
R Matsui, and K Kashihara, and T Higashi, and K Seo, and Y Taoka, and S Yoshida, and H Nishitani, and Y Takegawa, and Y Hukumura
January 2016, OncoTargets and therapy,
R Matsui, and K Kashihara, and T Higashi, and K Seo, and Y Taoka, and S Yoshida, and H Nishitani, and Y Takegawa, and Y Hukumura
March 2016, The British journal of dermatology,
R Matsui, and K Kashihara, and T Higashi, and K Seo, and Y Taoka, and S Yoshida, and H Nishitani, and Y Takegawa, and Y Hukumura
November 2016, Gan to kagaku ryoho. Cancer & chemotherapy,
R Matsui, and K Kashihara, and T Higashi, and K Seo, and Y Taoka, and S Yoshida, and H Nishitani, and Y Takegawa, and Y Hukumura
December 2019, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!